Aborted myocardial infarction in ST-elevation myocardial infarction: Insights from the STrategic Reperfusion Early after Myocardial infarction trial

Heart

Volumn 100, Issue 19, 2014, Pages 1543-1549

  Maleki, Neda Dianati ^a   Van De Werf, Frans ^b   Goldstein, Patrick ^c   Adgey, Jennifer A ^d   Lambert, Yves ^e   Sulimov, Vitaly ^f   Rosell Ortiz, Fernando ^g   Gershlick, Anthony H ^h   Zheng, Yinggan ^a   Westerhout, Cynthia M ^a   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

^e CENTRE HOSPITALIER DE VERSAILLES   (France)

^f I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^g Empresa Pública de Emergencias Sanitarias de Andalucía   (Spain)

^h UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARDIOVASCULAR AGENT; CREATINE KINASE MB; FIBRINOLYTIC AGENT; TROPONIN;

AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY INTERVENTION; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STANDARDS; STATISTICS AND NUMERICAL DATA; TIME TO TREATMENT; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CREATINE KINASE, MB FORM; EARLY MEDICAL INTERVENTION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; TIME-TO-TREATMENT; TREATMENT OUTCOME; TROPONIN;

EID: 84921688300     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-306023     Document Type: Article

References (15)

1. Lamfers EJ, Hooghoudt TE, Uppelschoten A, et al. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol 1999;84:928-7.
2. Lamfers EJ, Hooghoudt TE, Hertzberger DP, et al. Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis. Heart 2003;89:496-501.
3. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211-16.
4. Taher T, Fu Y, Wagner GS, et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol 2004;44:38-43.
5. Eitel I, Desch S, Sareban M, et al. Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty. Am Heart J 2009;158:806-13.
6. Patel MR, Westerhout CM, Granger CB, et al. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J 2013;165:226-33.
7. Verheugt FW, Gersh BJ, Armstrong PW. Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J 2006;27:901-4.
8. Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013;368:1379-87.
9. Armstrong PW, Gershlick A, Goldstein P, et al. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. Am Heart J 2010;160:30-5.
10. Buller CE, Fu Y, Mahaffey KW, et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 2008;118:1335-46.
11. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
12. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031-7.
13. Siha H, Das D, Fu Y, et al. Baseline Q-waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial. CMAJ 2012;184:1135-42.
14. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003;108:2851-6.
15. Bainey KR, Fu Y, Wagner GS, et al. Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments. Am Heart J 2008;156:248-55.